|
US20020164350A1
(en)
|
1992-09-03 |
2002-11-07 |
Lowy Douglas R. |
Chimeric papillomavirus-like particles
|
|
US5618536A
(en)
|
1992-09-03 |
1997-04-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chimeric papillomavirus-like particles
|
|
US8062642B1
(en)
|
1993-03-09 |
2011-11-22 |
University Of Rochester |
Production of papillomavirus capsid protein and virus-like particles
|
|
US20020039584A1
(en)
|
1998-02-20 |
2002-04-04 |
Medigene Ag |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
GB9806666D0
(en)
|
1998-03-27 |
1998-05-27 |
Stanley Margaret |
Antigen preparation and use
|
|
EA004497B1
(ru)
|
1998-12-04 |
2004-04-29 |
Байоджен, Инк. |
Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов
|
|
SE514982C2
(sv)
|
1999-09-30 |
2001-05-28 |
Active Biotech Ab |
Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
|
|
CN1114690C
(zh)
|
2001-05-15 |
2003-07-16 |
乔良 |
乳头瘤假病毒及其制备方法
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
GB2392158B
(en)
|
2002-08-21 |
2005-02-16 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof
|
|
KR20050114225A
(ko)
|
2003-03-07 |
2005-12-05 |
머크 앤드 캄파니 인코포레이티드 |
인플루엔자 바이러스 백신
|
|
AU2004238843B2
(en)
*
|
2003-05-09 |
2009-04-23 |
Research Development Foundation |
Insertion of furin protease cleavage sites in membrane proteins and uses thereof
|
|
WO2006037787A2
(en)
|
2004-10-05 |
2006-04-13 |
Cytos Biotechnology Ag |
Vlp-antigen conjugates and their uses as vaccines
|
|
KR20080015854A
(ko)
|
2005-06-14 |
2008-02-20 |
사이토스 바이오테크놀로지 아게 |
항원 컨쥬게이트 및 그의 용도
|
|
US20070160628A1
(en)
|
2005-08-31 |
2007-07-12 |
Birkett Ashley J |
Stabilized virus-like particles and epitope display systems
|
|
US20070104689A1
(en)
*
|
2005-09-27 |
2007-05-10 |
Merck Patent Gmbh |
Compositions and methods for treating tumors presenting survivin antigens
|
|
JP5564181B2
(ja)
|
2005-12-08 |
2014-07-30 |
シルワン，ハヴァル |
免疫刺激組成物および方法
|
|
WO2008082719A2
(en)
*
|
2006-08-30 |
2008-07-10 |
University Of Rochester |
Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
|
|
HUE030437T2
(en)
|
2007-05-08 |
2017-05-29 |
Us Health |
Papillomavirus pseudoviruses for detection and therapy of tumors
|
|
US8088392B2
(en)
|
2007-06-18 |
2012-01-03 |
Yunxu Cao |
Capsid proteins and uses therefore
|
|
US20100260792A1
(en)
*
|
2007-10-22 |
2010-10-14 |
University Of Rochester |
Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
|
|
WO2009092113A2
(en)
|
2008-01-19 |
2009-07-23 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for the delivery of vaccines to disrupted epithelium
|
|
EP2288380B1
(en)
|
2008-06-09 |
2020-06-03 |
Bharat Biotech International Limited |
Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
|
|
WO2010118424A2
(en)
|
2009-04-10 |
2010-10-14 |
The Johns Hopkins University |
Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
|
|
EP3427755B1
(en)
|
2009-04-13 |
2020-10-21 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Hpv particles and uses thereof
|
|
AU2010243285B2
(en)
*
|
2009-04-30 |
2013-06-06 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
CN102869384B
(zh)
*
|
2009-06-22 |
2016-01-13 |
伯纳姆医学研究所 |
使用带有c-端元件的肽和蛋白质的方法和组合物
|
|
WO2012033911A2
(en)
|
2010-09-08 |
2012-03-15 |
The Johns Hopkins University |
Polyionic papilloma virus-like particle (vlp) vaccines
|
|
CN102153656B
(zh)
|
2011-01-12 |
2014-11-19 |
广州市元通医药科技有限公司 |
一种嵌合病毒样颗粒疫苗及其制备方法
|
|
JP6130307B2
(ja)
|
2011-03-17 |
2017-05-17 |
ザ ユニバーシティ オブ バーミンガム |
再指向性免疫療法
|
|
WO2012141984A1
(en)
*
|
2011-04-08 |
2012-10-18 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
JP2014521687A
(ja)
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
|
|
SG11201401579UA
(en)
|
2011-12-01 |
2014-07-30 |
Univ Cape Town |
Hpv chimaeric particle
|
|
WO2013119877A1
(en)
|
2012-02-07 |
2013-08-15 |
Aura Biosciences, Inc. |
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
|
|
US9561275B2
(en)
|
2012-09-14 |
2017-02-07 |
The Johns Hopkins University |
Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
|
|
US20160206715A1
(en)
|
2013-03-15 |
2016-07-21 |
Bullet Biotechnology, Inc. |
Specific multivalent virus-like particle vaccines and uses thereof
|
|
MX385842B
(es)
|
2013-09-18 |
2025-03-18 |
Aura Biosciences Inc |
Conjugados de partículas de tipo virus y uso de las mismas.
|
|
CA2939093A1
(en)
*
|
2014-02-14 |
2015-08-20 |
Immune Design Corp. |
Immunotherapy of cancer through combination of local and systemic immune stimulation
|
|
US10413603B2
(en)
|
2014-06-19 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for improved human papilloma virus constructs
|
|
CA2967336C
(en)
*
|
2014-11-07 |
2023-09-26 |
Case Western Reserve University |
Cancer immunotherapy using virus particles
|
|
WO2016112921A1
(en)
|
2015-01-15 |
2016-07-21 |
University Of Copenhagen |
Virus-like particle with efficient epitope display
|
|
EP3258969B1
(en)
|
2015-02-18 |
2019-03-20 |
F. Hoffmann-La Roche AG |
Immunoconjugates for specific induction of t cell cytotoxicity against a target cell
|
|
WO2016176164A1
(en)
|
2015-04-28 |
2016-11-03 |
Albert Einstein College Of Medicine, Inc. |
Treatment of cancer using recall antigens delivered by attenuated bacteria
|
|
WO2017020570A1
(en)
|
2015-08-06 |
2017-02-09 |
Medigen Biotechnology Corp. |
Virus-like particle vaccines
|
|
CA2996762A1
(en)
*
|
2015-08-31 |
2017-03-09 |
Technovax, Inc. |
Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine
|
|
WO2017075615A1
(en)
|
2015-10-29 |
2017-05-04 |
Bullet Biotechnology, Inc. |
Virus-like particle intermediates, agents attached thereto, methods for making and uses thereof
|
|
US20180311374A1
(en)
*
|
2015-10-30 |
2018-11-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Targeted cancer therapy
|
|
ES2854726T3
(es)
|
2015-10-30 |
2021-09-22 |
The Univ Of Copenhagen |
Partícula similar a virus con presentación eficiente de epítopos
|
|
WO2017075440A1
(en)
|
2015-10-30 |
2017-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Targeted cancer therapy
|
|
US10722537B2
(en)
|
2015-11-06 |
2020-07-28 |
Regents Of The University Of Minnesota |
Activation of resident memory T cells for cancer immunotherapy
|
|
ES2873846T5
(en)
|
2015-11-19 |
2025-06-23 |
Revitope Ltd |
Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells
|
|
WO2017112830A1
(en)
|
2015-12-21 |
2017-06-29 |
La Jolla Institute For Allergy And Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
US11351237B2
(en)
|
2015-12-22 |
2022-06-07 |
Thomas Jefferson University |
CMV-based intra-tumoral cancer therapies
|
|
WO2017177204A1
(en)
|
2016-04-09 |
2017-10-12 |
La Jolla Institute For Allergy And Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
US20200078401A1
(en)
*
|
2016-12-07 |
2020-03-12 |
La Jolla Institute For Allergy And Immunology |
Compositions for cancer treatment and methods and uses for cancer treatment and prognosis
|
|
US11197890B2
(en)
*
|
2016-12-12 |
2021-12-14 |
New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery |
Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines
|
|
KR102797824B1
(ko)
*
|
2017-06-23 |
2025-04-17 |
버이뮨 아이엔씨. |
키메라 바이러스-유사 입자 및 면역 반응의 항원-특이적 재지향자로서의 이의 용도
|
|
EP3661550A4
(en)
|
2017-08-03 |
2021-08-04 |
Regents of the University of Minnesota |
ACTIVATION OF LYMPHOCYTES T MEMORY RESIDENTS FOR THE TREATMENT OF CANCER
|
|
EP3706783A1
(en)
|
2017-11-06 |
2020-09-16 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Cancer treatment utilizing pre-existing microbial immunity
|
|
EP3823668A1
(en)
|
2018-07-16 |
2021-05-26 |
DCPrime B.V. |
A combination product for use in tumor vaccination
|
|
SG11202106931PA
(en)
*
|
2018-12-27 |
2021-07-29 |
Verimmune Llc |
Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
|
|
KR20210151848A
(ko)
|
2019-03-26 |
2021-12-14 |
아우라 바이오사시언시스, 인크. |
인간 파필로마바이러스 나노입자 제제
|